Mechanisms of vascular calcification in uremia
Vascular calcification and cardiovascular disease mortality are highly correlated with increased serum phosphate levels in end-stage renal disease patients. Mechanistic studies in cultured human smooth muscle cells (SMCs) indicate that increased phosphate levels induces both calcification and phenotypic transition through a pathway requiring a sodium-dependent phosphate cotransporter. Thus, in addition to contributing to increased calcium × phosphate product (Ca × P), hyperphosphatemia may have direct effects on SMCs that predispose these cells to calcium deposition in end-stage renal disease patients.
Keywords: vascular calcification , uremia , sodium-dependent phosphate cotransporter , biomineralization , hyperphosphatemia
To access this article, please choose from the options below
Supported by National Institutes of Health grant HL62329, National Science Foundation UWEB ERC EEC9529161, and a grant from Genzyme, Boston, MA.
PII: S0270-9295(04)00088-9
doi:10.1016/j.semnephrol.2004.06.005
© 2004 Elsevier Inc. All rights reserved.
